Should Intra-cerebrospinal Fluid Prophylaxis Be Part of Initial Therapy for Patients With Non-Hodgkin Lymphoma: What We Know, and How We Can Find Out More

Ulrich Herrlinger, Michael Glantz, Uwe Schlegel, Christian Gisselbrecht, Franco Cavalli

Research output: Contribution to journal › Article › peer-review

18 Citations (SciVal)

Fingerprint

Dive into the research topics of 'Should Intra-cerebrospinal Fluid Prophylaxis Be Part of Initial Therapy for Patients With Non-Hodgkin Lymphoma: What We Know, and How We Can Find Out More'. Together they form a unique fingerprint.

Medicine & Life Sciences